Collegium closes $980M syndicated credit facility, repays Pharmakon loan

COLLEGIUM PHARMACEUTICAL, INC

$980M total facility: $580M term loan, $300M delayed draw, $100M revolver; matures 2030.
Initial term loan used to repay ~$581M of existing Pharmakon debt; previous facility was $646M.
Interest rate SOFR + 2.75%–3.75% (initial 2.75%), expected to deliver meaningful annualized interest savings.
Delayed draw and revolver undrawn at close; earmarked for general corporate purposes and M&A.
Truist Bank administrative agent; bank syndicate includes Citizens, MUFG, Fifth Third, Huntington, U.S. Bank.

item 1.01 item 1.02 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

COLLEGIUM PHARMACEUTICAL, INC entered into Credit Agreement with Truist Bank, as administrative agent valued at $580,000,000 term loan, $300,000,000 of delayed draw term loan commitments, and a $100,000,000 revol (effective 2025-12-23).

Action: entry
Agreement: credit facility
Counterparty: Truist Bank, as administrative agent
Value: $580,000,000 term loan, $300,000,000 of delayed draw term loan commitments, and a $100,000,000 revol
Effective: 2025-12-23

Exact text from the filing

On December 23, 2025, Collegium Pharmaceutical, Inc. (the “Company”) entered into a Credit Agreement by and among the Company, the lenders from time to time party thereto and Truist Bank, as administrative agent (the “Credit Agreement”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

COLLEGIUM PHARMACEUTICAL, INC terminated Second Amended and Restated Loan Agreement with Biopharma Credit PLC, as collateral agent (effective 2025-12-23).

Action: termination
Agreement: credit facility
Counterparty: Biopharma Credit PLC, as collateral agent
Effective: 2025-12-23

Exact text from the filing

On December 23, 2025, in connection with its entry into the Credit Agreement, the Company repaid in full all obligations outstanding under the Existing Credit Agreement.

View on SEC.gov

290 material agreements filed in the last 30 days. Browse all material agreements →

COLLEGIUM PHARMACEUTICAL, INC filing history →

Source: SEC EDGAR

accession 0001104659-25-125026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.